Press Releases

A Year Since BIO
Press Release
A Year Since BIO
Posted on
CVC successfully appeals prior CRISPR U.S. patent decision
Press Release
CVC successfully appeals prior CRISPR U.S. patent decision
Posted on
AI + CRISPR: Powering the 21st Century’s Biological Revolution 
Press Release
AI + CRISPR: Powering the 21st Century’s Biological Revolution 
Posted on
ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement 
Press Release
ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement 
Posted on
European Patent Office Grants CVC Portfolio Key CRISPR Patent
Press Release
European Patent Office Grants CVC Portfolio Key CRISPR Patent
Posted on
Annual Letter From The CEO
Press Release
Annual Letter From The CEO
Posted on
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9 
Press Release
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9 
Posted on
A Letter from the CEO
Article
A Letter from the CEO
Posted on
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics appoints John E Milad as Chief Executive Officer
Press Release
ERS Genomics appoints John E Milad as Chief Executive Officer
Posted on
Update: Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Press Release
Update: Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Posted on
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Press Release
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Posted on
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
Posted on
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Press Release
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Posted on
New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
Press Release
New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
Posted on
ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International
Press Release
ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International
Posted on
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Posted on
ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
Posted on